694 / 1068
Rectal Cancer Stage II/III
Disease-free Survival
Colon Cancer Stage II/III
n
Absolute
Difference
HR P-value
MOSAIC
2246
5% (3y)
0.77 .002
NSABP C-07
2407
4% (3y)
0.80 .003
Neoadjuvant oxaliplatin
ACCORD 12
584
4.3% (5y)
0.86 0.25
NSAPB R-04
1284
5% (5y)
0.91 0.34
CAO/ARO/AIO-04
1236
4.7% (3y)
0.79 0.03
Chinese
206
10.6% (3y)
n.g.
0.08
STAR-01 and
full paper of
PETACC-6 pending